MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 165 filers reported holding MOMENTA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,430,000 | -23.0% | 102,483 | +2.0% | 0.05% | -26.5% |
| Q3 2017 | $1,858,000 | +11.1% | 100,428 | +1.4% | 0.07% | +4.6% |
| Q2 2017 | $1,672,000 | +29.8% | 99,001 | +2.7% | 0.06% | +25.0% |
| Q1 2017 | $1,288,000 | -6.7% | 96,444 | +5.1% | 0.05% | -11.9% |
| Q4 2016 | $1,381,000 | +29.1% | 91,786 | +0.3% | 0.06% | +25.5% |
| Q3 2016 | $1,070,000 | +116.2% | 91,540 | +99.8% | 0.05% | +113.6% |
| Q2 2016 | $495,000 | +18.4% | 45,825 | +1.2% | 0.02% | +22.2% |
| Q1 2016 | $418,000 | -37.8% | 45,269 | 0.0% | 0.02% | -40.0% |
| Q4 2015 | $672,000 | -8.6% | 45,269 | +1.1% | 0.03% | -16.7% |
| Q3 2015 | $735,000 | -28.0% | 44,795 | 0.0% | 0.04% | -20.0% |
| Q2 2015 | $1,021,000 | +49.9% | 44,795 | 0.0% | 0.04% | +45.2% |
| Q1 2015 | $681,000 | +26.3% | 44,795 | 0.0% | 0.03% | +19.2% |
| Q4 2014 | $539,000 | +6.1% | 44,795 | 0.0% | 0.03% | +4.0% |
| Q3 2014 | $508,000 | -6.1% | 44,795 | 0.0% | 0.02% | -7.4% |
| Q2 2014 | $541,000 | +3.6% | 44,795 | 0.0% | 0.03% | 0.0% |
| Q1 2014 | $522,000 | – | 44,795 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 159,197 | $5,296,000 | 4.06% |
| Ghost Tree Capital, LLC | 385,000 | $12,809,000 | 3.38% |
| Copernicus Capital Management, LLC | 88,000 | $2,928,000 | 3.21% |
| Palo Alto Investors LP | 1,479,524 | $49,224,000 | 2.96% |
| Redmile Group, LLC | 4,705,308 | $156,546,000 | 2.89% |
| Avidity Partners Management LP | 1,150,000 | $38,261,000 | 2.45% |
| RA Capital Management | 2,531,445 | $84,221,000 | 1.64% |
| MAVERICK CAPITAL LTD | 2,314,756 | $77,012,000 | 1.62% |
| Integral Health Asset Management, LLC | 150,000 | $4,991,000 | 1.50% |
| PFM Health Sciences, LP | 579,994 | $19,296,000 | 1.00% |